Open AccessVenous thromboembolism prophylaxis in inflammatory bowel disease flare-ups
Author(s) -
Osama Kaddourah,
Laith Numan,
Sravan Jeepalyam,
Omar Abughanimeh,
Mouhanna Abu Ghanimeh,
Khalil Abuamr
Publication year - 2019
Publication title -
annals of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.886
H-Index - 33
eISSN - 1792-7463
pISSN - 1108-7471
DOI - 10.20524/aog.2019.0412
Subject(s) - medicine , hematochezia , inflammatory bowel disease , incidence (geometry) , aspirin , ulcerative colitis , gastrointestinal bleeding , disease , colonoscopy , physics , colorectal cancer , cancer , optics
Inflammatory bowel disease (IBD) is a set of chronic inflammatory diseases associated with significant morbidity. Generally, IBD patients have twice the risk of venous thromboembolism (VTE) compared to healthy controls. VTE in IBD is associated with greater morbidity and mortality. This is compounded by the underutilization of pharmacological anticoagulation in hospitalized patients with IBD. One study showed that half the IBD patients who developed VTE were not receiving any thrombotic prophylaxis.